Cardiac-specific and ligand-inducible target gene expression in transgenic mice

Jacqueline Bo, Wei Yu, Ying Min Zhang, Francesco J. Demayo, Lei Wei

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Conditional transgene expression in the heart is a useful approach to explore the physiological basis of the cardiac phenotype. The present study describes the development of a binary transgenic system in which transgene expression in the mouse heart can be turned on/off by administration/withdrawal of an exogenous compound. We generated a transgenic line (αMHC-Glp 65) harboring a mifepristone (RU486)-controlled chimeric transcription factor (Glp 65) under the regulatory control of the cardiac-specific α-myosin heavy chain (αMHC) promoter. In the presence of RU486, Glp 65 expressed in the heart is able to bind to a target gene promoter containing four copies of the 17-mer GAL4 binding site, resulting in ligand-inducible transactivation of the target gene. We tested this system by crossing the transgenic mice, αMHC-Glp 65, with a transgenic line harboring human growth hormone (hGH) target gene. We observed that expression of hGH could be induced in adults as well as in the embryonic hearts of bigenic mice by RU486. The basal hGH expression was very low and the inducible level in the heart was estimated over 800-fold higher versus the basal level after 4:days of administration of RU486 at 500:μg/kg body weight per day at 2-5:months of age. The level of the transgene returned to the basal level within 7:days after withdrawal of RU486. This system can be used to control cardiac-specific expression of transgene in a time- and dose-dependent manner.

Original languageEnglish (US)
Pages (from-to)685-691
Number of pages7
JournalJournal of Molecular and Cellular Cardiology
Volume38
Issue number4
DOIs
StatePublished - Apr 2005
Externally publishedYes

Fingerprint

Transgenic Mice
Transgenes
Human Growth Hormone
Myosin Heavy Chains
Ligands
Gene Expression
Cardiac Myosins
Genes
Mifepristone
Transcriptional Activation
Transcription Factors
Binding Sites
Body Weight
Phenotype

Keywords

  • Binary transgenic mouse
  • Cardiac-specific
  • Gene-switch
  • Inducible transgene expression
  • Mifepristone-induced gene regulatory system

ASJC Scopus subject areas

  • Molecular Biology
  • Cardiology and Cardiovascular Medicine

Cite this

Cardiac-specific and ligand-inducible target gene expression in transgenic mice. / Bo, Jacqueline; Yu, Wei; Zhang, Ying Min; Demayo, Francesco J.; Wei, Lei.

In: Journal of Molecular and Cellular Cardiology, Vol. 38, No. 4, 04.2005, p. 685-691.

Research output: Contribution to journalArticle

Bo, Jacqueline ; Yu, Wei ; Zhang, Ying Min ; Demayo, Francesco J. ; Wei, Lei. / Cardiac-specific and ligand-inducible target gene expression in transgenic mice. In: Journal of Molecular and Cellular Cardiology. 2005 ; Vol. 38, No. 4. pp. 685-691.
@article{b9648530106844429df893f05bdcdbf6,
title = "Cardiac-specific and ligand-inducible target gene expression in transgenic mice",
abstract = "Conditional transgene expression in the heart is a useful approach to explore the physiological basis of the cardiac phenotype. The present study describes the development of a binary transgenic system in which transgene expression in the mouse heart can be turned on/off by administration/withdrawal of an exogenous compound. We generated a transgenic line (αMHC-Glp 65) harboring a mifepristone (RU486)-controlled chimeric transcription factor (Glp 65) under the regulatory control of the cardiac-specific α-myosin heavy chain (αMHC) promoter. In the presence of RU486, Glp 65 expressed in the heart is able to bind to a target gene promoter containing four copies of the 17-mer GAL4 binding site, resulting in ligand-inducible transactivation of the target gene. We tested this system by crossing the transgenic mice, αMHC-Glp 65, with a transgenic line harboring human growth hormone (hGH) target gene. We observed that expression of hGH could be induced in adults as well as in the embryonic hearts of bigenic mice by RU486. The basal hGH expression was very low and the inducible level in the heart was estimated over 800-fold higher versus the basal level after 4:days of administration of RU486 at 500:μg/kg body weight per day at 2-5:months of age. The level of the transgene returned to the basal level within 7:days after withdrawal of RU486. This system can be used to control cardiac-specific expression of transgene in a time- and dose-dependent manner.",
keywords = "Binary transgenic mouse, Cardiac-specific, Gene-switch, Inducible transgene expression, Mifepristone-induced gene regulatory system",
author = "Jacqueline Bo and Wei Yu and Zhang, {Ying Min} and Demayo, {Francesco J.} and Lei Wei",
year = "2005",
month = "4",
doi = "10.1016/j.yjmcc.2005.01.010",
language = "English (US)",
volume = "38",
pages = "685--691",
journal = "Journal of Molecular and Cellular Cardiology",
issn = "0022-2828",
publisher = "Academic Press Inc.",
number = "4",

}

TY - JOUR

T1 - Cardiac-specific and ligand-inducible target gene expression in transgenic mice

AU - Bo, Jacqueline

AU - Yu, Wei

AU - Zhang, Ying Min

AU - Demayo, Francesco J.

AU - Wei, Lei

PY - 2005/4

Y1 - 2005/4

N2 - Conditional transgene expression in the heart is a useful approach to explore the physiological basis of the cardiac phenotype. The present study describes the development of a binary transgenic system in which transgene expression in the mouse heart can be turned on/off by administration/withdrawal of an exogenous compound. We generated a transgenic line (αMHC-Glp 65) harboring a mifepristone (RU486)-controlled chimeric transcription factor (Glp 65) under the regulatory control of the cardiac-specific α-myosin heavy chain (αMHC) promoter. In the presence of RU486, Glp 65 expressed in the heart is able to bind to a target gene promoter containing four copies of the 17-mer GAL4 binding site, resulting in ligand-inducible transactivation of the target gene. We tested this system by crossing the transgenic mice, αMHC-Glp 65, with a transgenic line harboring human growth hormone (hGH) target gene. We observed that expression of hGH could be induced in adults as well as in the embryonic hearts of bigenic mice by RU486. The basal hGH expression was very low and the inducible level in the heart was estimated over 800-fold higher versus the basal level after 4:days of administration of RU486 at 500:μg/kg body weight per day at 2-5:months of age. The level of the transgene returned to the basal level within 7:days after withdrawal of RU486. This system can be used to control cardiac-specific expression of transgene in a time- and dose-dependent manner.

AB - Conditional transgene expression in the heart is a useful approach to explore the physiological basis of the cardiac phenotype. The present study describes the development of a binary transgenic system in which transgene expression in the mouse heart can be turned on/off by administration/withdrawal of an exogenous compound. We generated a transgenic line (αMHC-Glp 65) harboring a mifepristone (RU486)-controlled chimeric transcription factor (Glp 65) under the regulatory control of the cardiac-specific α-myosin heavy chain (αMHC) promoter. In the presence of RU486, Glp 65 expressed in the heart is able to bind to a target gene promoter containing four copies of the 17-mer GAL4 binding site, resulting in ligand-inducible transactivation of the target gene. We tested this system by crossing the transgenic mice, αMHC-Glp 65, with a transgenic line harboring human growth hormone (hGH) target gene. We observed that expression of hGH could be induced in adults as well as in the embryonic hearts of bigenic mice by RU486. The basal hGH expression was very low and the inducible level in the heart was estimated over 800-fold higher versus the basal level after 4:days of administration of RU486 at 500:μg/kg body weight per day at 2-5:months of age. The level of the transgene returned to the basal level within 7:days after withdrawal of RU486. This system can be used to control cardiac-specific expression of transgene in a time- and dose-dependent manner.

KW - Binary transgenic mouse

KW - Cardiac-specific

KW - Gene-switch

KW - Inducible transgene expression

KW - Mifepristone-induced gene regulatory system

UR - http://www.scopus.com/inward/record.url?scp=16244386276&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=16244386276&partnerID=8YFLogxK

U2 - 10.1016/j.yjmcc.2005.01.010

DO - 10.1016/j.yjmcc.2005.01.010

M3 - Article

C2 - 15808845

AN - SCOPUS:16244386276

VL - 38

SP - 685

EP - 691

JO - Journal of Molecular and Cellular Cardiology

JF - Journal of Molecular and Cellular Cardiology

SN - 0022-2828

IS - 4

ER -